Accretion Pharmaceuticals Ltd vs Ishita Drugs Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 114.65 as of 18 May 15:30 . The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Ishita Drugs & Industries Ltd changed from 10.8 on March 2021 to 27.1 on March 2025 . This represents a CAGR of 20.20% over 5 years The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Ishita Drugs & Industries Ltd changed from ₹ 8.97 crore on March 2021 to ₹ 23.48 crore on March 2025 . This represents a CAGR of 21.22% over 5 years The revenue of Accretion Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 3.23 crore as compare to the Sep '25 revenue of ₹ 3.14 crore. This represent the growth of 2.87% The ebitda of Accretion Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 0.24 crore as compare to the Sep '25 ebitda of ₹ 0.25 crore. This represent the decline of -4% The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Ishita Drugs & Industries Ltd changed from ₹ 0.15 crore to ₹ 0.16 crore over 7 quarters. This represents a CAGR of 3.76% The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Ishita Drugs & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014.
Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal.
The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient.
The company supplies its products to leading pharmaceutical companies of India.
The products are also being exported to various countries across the world.
The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad.

FAQs for the comparison of Accretion Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Ishita Drugs & Industries Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 127 Cr while Market cap of Ishita Drugs & Industries Ltd is 23 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd?

As of May 18, 2026, the Accretion Pharmaceuticals Ltd stock price is INR ₹114.65. On the other hand, Ishita Drugs & Industries Ltd stock price is INR ₹78.0.

How do dividend payouts of Accretion Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Ishita Drugs & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.